VAPO - Vapotherm, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• NYSE to suspend Vapotherm listing immediately, to trade on OTCQX from today
• Vapotherm slips on announcing voluntary delisting from NYSE to OTCQX Marketplace
• Vapotherm GAAP EPS of -$2.38 misses by $0.18, revenue of $15.2M misses by $1.52M
• Vapotherm high velocity therapy outperforms in children with asthma
• Vapotherm President/CEO buys 100,000 common shares
• Vapotherm reports mixed Q2 earnings; updates FY23 outlook
• Vapotherm GAAP EPS of -$0.45 misses by $0.02, revenue of $17.7M misses by $0.65M
• Cara, Iovance, and Karyopharm among biotechs with no exposure to SVB (updated)
• Vapotherm GAAP EPS of -$0.78 in-line, revenue of $18.7M beats by $0.84M
• Vapotherm prices scales 13%, CEO buys stock worth $500K
• Vapotherm announces $23M private placement
• Vapotherm crashes 45% as FY22 outlook cut again amid Q3 revenue slump
• Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M
• Vapotherm draws downgrade at William Blair after 2Q results
• Vapotherm stock sheds ~31% as Q2 results disappoint, co cuts FY 2022 revenue guidance
• Vapotherm GAAP EPS of -$1.61 misses by $0.86, revenue of $13M misses by $5.35M, cuts FY22 revenue guidance
• Catalyst watch: Change Health/UNH DOJ court starts, PayPal earnings, unemployment data
• Vapotherm downgraded to hold at Canaccord on 'transition years' ahead
• Vapotherm GAAP EPS of -$0.87 misses by $0.22, revenue of $21.62M beats by $0.59M
• Vapotherm sinks 20%+ after Piper Sandler cuts rating following disappointing guidance